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Caloric restriction (CR) is standard lifestyle therapy
in obesity management. CR-induced weight loss
improves the metabolic profile of individuals with
obesity. Inmice, occurrence of beige fat cells in white
fat depots favors a metabolically healthy phenotype,
and CR promotes browning of white adipose tissue
(WAT). Here, human subcutaneous abdominal WAT
samples were analyzed in 289 individuals with
obesity following a two-phase dietary intervention
consisting of an 8 week very low calorie diet and a
6-month weight-maintenance phase. Before the
intervention, we show sex differences and seasonal
variation, with higher expression of brown and beige
markers in women with obesity and during winter,
respectively. The very low calorie diet resulted in
decreased browning of subcutaneous abdominal
WAT. During thewhole dietary intervention, evolution
of body fat and insulin resistancewas independent of
changes in brown and beige fat markers. These data
suggest that diet-induced effects on body fat and in-
sulin resistance are independent of subcutaneous
abdominal WAT browning in people with obesity.
INTRODUCTION
Dysregulated balance between energy intake and energy expen-
diture promotes storage of nutrient oversupply in white adipose
tissue (WAT). An excess of fat mass is the hallmark of obesity,
which leads to various metabolic disorders, such as cardiovas-
cular diseases and type 2 diabetes. Achievement of negative
energy balance through caloric restriction (CR) is a common
strategy in the clinical management of obesity. CR-inducedCell Re
This is an open access article under the CC BY-Nweight loss has been reported to reduce insulin resistance
and improve most of the metabolic abnormalities seen in obesity
(Andersen and Fernandez, 2013; Soare et al., 2014). It efficiently
lowers diabetes risk (Hamman et al., 2006).
Targeting molecular pathways that regulate thermogenesis
may provide a plausible means of increasing energy expenditure
(Crowley et al., 2002; Giordano et al., 2016). Brown adipose tis-
sue (BAT) has attracted much interest as the tissue controlling
adaptive thermogenesis. Besides BAT depots at discrete
anatomical sites, brown-like adipocytes, known as beige (or brite
[brown-in-white]) adipocytes, have been identified within white
fat depots, notably inguinal subcutaneous WAT in rodents.
Mouse strains genetically prone to white fat browning are pro-
tected from obesity (Collins et al., 1997; Vitali et al., 2012),
whereas high-fat-fed mice deficient for PRDM16, a transcrip-
tional regulator driving browning, become obese and insulin
resistant compared with wild-type mice (Cohen et al., 2014). In
rodents, browning of WAT occurs in response to various stimuli,
including cold (Cousin et al., 1992), pharmacological treatment
(Himms-Hagen et al., 2000), and weight loss induced by surgery
(Neinast et al., 2015). As the beneficial effects of CR have partly
been ascribed to adaptations of energy-sensing pathways
(Canto´ and Auwerx, 2009), and as CR was recently reported to
induce white fat browning in mice (Fabbiano et al., 2016), we hy-
pothesized that browning of WAT in humans may be involved in
the metabolic benefits elicited by CR. In this study, we therefore
aimed to determine whether browning of WAT participates in
changes in body fat induced by CR in people with obesity. First,
we selected markers of brown, beige, and white adipocytes and
established their cell specificity within human WAT. We then
measured gene expression of the markers in the subcutaneous
fat of 289 men and women with overweight and obesity from
the DiOGenes (diet, obesity, and genes) trial at baseline, after
an 8week very low calorie diet (VLCD) and at the end of a 6month
follow-up period (Larsen et al., 2010). Expression of UCP1, the
prototypical uncoupling protein responsible for dissipation ofports 22, 1079–1089, January 23, 2018 ª 2018 The Authors. 1079
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1. Top-Ranking Genes Displaying Highest Correlations
with UCP1 mRNA Level at Baseline (n = 289)
Gene Name r Bonferroni-Adjusted p Value
ELOVL3 0.56 <1022
CKMT2 0.55 <1021
CKMT1a 0.49 <1015
PPARGC1B 0.46 <1013
PCK1 0.40 <109
PLIN5 0.32 <105the proton electrochemical gradient generated by the mitochon-
drial respiratory chain in brown adipocytes, and other brown fat
markers showed higher expression in women than men and
during winter compared with summer. During the negative
energy balance phase induced by VLCD, a decrease in brown
fat features was observed in subcutaneous fat. In the two phases
of the dietary program, browning of WAT was not associated
with loss of body fat and improvement of insulin sensitivity.
Our data suggest that browning of subcutaneous abdominal
fat does not participate in the beneficial effects of CR and diet-
induced weight loss in humans.
RESULTS AND DISCUSSION
UCP1 mRNA Levels Are Correlated with Gene
Expression of Thermogenic Markers but Not of Brown-
and Beige-Specific Markers, in Human Subcutaneous
Abdominal WAT
Numerous markers have been suggested to be specific to
white, beige, and brown adipocytes. In addition to UCP1, we
selected 90 genes related to the fat cell subtypes and adipose
metabolism (Table S1). Because our major goal was to probe
the extent of browning in a large biobank of human subcutane-
ous fat, we first determined whether these potential markers
were preferentially expressed in adipocytes compared with
other WAT cell types. To that end, subcutaneous abdominal
fat samples from seven individuals were digested by collage-
nase to isolate mature adipocytes and stromavascular fraction
cells. In order to focus on genes with robust fat cell expression,
genes displaying more than 2-fold higher expression in the
stromavascular fraction compared with mature adipocytes
were removed in subsequent analyses. We also removed
from the initial list genes whose expression levels were below
the threshold of detection in more than 75% of DiOGenes trial
fat samples. The final selection comprised 70 genes that were
classified according to their expression in adipocyte subtypes
as reported in the literature and according to our own published
and unpublished datasets on human adipocytes converted
in vitro in beige fat cells (Ahfeldt et al., 2012; Barquissau
et al., 2016; Kazak et al., 2015; Lidell et al., 2013; Sharp et al.,
2012; Walde´n et al., 2012; Wu et al., 2012). The classification
showed a large overlap between the categories, as only 3, 7,
and 2 genes were classified as specific to white, beige, and
brown adipocytes, respectively (Figure S1A; Table S1). Corre-
lation matrix analysis of the 12 specific markers and UCP1 in
subcutaneous WAT from 289 DiOGenes trial participants at1080 Cell Reports 22, 1079–1089, January 23, 2018baseline showed weak association between UCP1 and brown-
and beige-specific markers in the context of whole humanWAT
(Figure S1B). Accordingly, the relevance of currently known
brown- and beige-specific markers has been questioned, as
they prove not to be robustly and consistently induced upon
browning according to mouse strains, age of animals, and loca-
tion of fat depots or when in vivo and in vitro browning of fat
cells are compared (de Jong et al., 2015; Garcia et al., 2016).
We therefore extended search for genes correlating with
UCP1 to the whole list (i.e., 70 genes) comprising several genes
with well-known functions in brown fat metabolism. The highest
correlations were found for ELOVL3, CKMT2, CKMT1A,
PPARGC1B, PCK1, and PLIN5 (Table 1). ELOVL3 is a fatty
acid elongase highly expressed in BAT (Tvrdik et al., 1997).
Its expression is upregulated during browning of human adipo-
cytes (Barquissau et al., 2016). CKMT-driven creatine cycle has
recently been involved in a UCP1-independent thermogenic
pathway (Bertholet et al., 2017; Kazak et al., 2015). PPARGC1B
contributes to brown fat development (Uldry et al., 2006). PLIN5
and PCK1 are involved in metabolic pathways supporting ther-
mogenic function (Barquissau et al., 2016; Wolins et al., 2006).
Therefore, expression of UCP1 and other genes with estab-
lished functions in brown fat cells in this biobank of fat samples
may not be incidental and may reflect the occurrence of bona
fide thermogenic adipocytes in human subcutaneous abdom-
inal WAT.
UCP1 Gene Expression in Subcutaneous Abdominal
WAT Shows Large Inter-individual Variability and Is Sex
and Season Dependent
At baseline,UCP1mRNA levels in subcutaneousWAT showed a
wide range of expression, from the limit of detection to 500-fold
higher. Hierarchical clustering of individuals according to UCP1
mRNA levels distinguished three groups with high, medium, and
low UCP1 expression (Figures 1A and S1C). ELOVL3, CKMT1a,
CKMT2, PPARGC1B, PCK1, and PLIN5 displayed a gradually
decreased expression in high, medium, and low UCP1 groups
(Figure 1A). Most of the correlations between these genes and
UCP1 were conserved when high/medium and low UCP1
groups were analyzed separately (Table S2). UCP1 mRNA level
in females was 5-fold higher compared with males (Figure 1B).
Higher gene expression in females than in males was also found
for ELOVL3, CKMT1a, CKMT2, PPARGC1B, PCK1, and PLIN5.
Most of the correlations between these genes and UCP1 were
significant in males and females (Table S2). Consistent with re-
sults in the entire set of patients (Figure 1A), differential expres-
sion of UCP1 and associated markers in high-, medium-, and
low-UCP1 groups were preserved when males and females
were separately analyzed (Figures S2A–S2G). Hence, there
was a major distortion in sex distribution between groups:
high- and medium-UCP1 groups included 100% and 93%
females, respectively, whereas the low-UCP1 group was
composed of 55% females and 45% males (Figure S2H). Such
sex difference has been shown for active BAT, which is detected
more frequently in females than in males (Cypess et al., 2009;
Nookaew et al., 2013). As patients had been recruited all year
round, we investigated the effect of seasons on expression of
brown and beige fat markers. UCP1 gene expression was
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Figure 1. UCP1Gene Expression in Subcutaneous AbdominalWhite Adipose Tissue Shows Inter-individual Variability and Is Sex and Season
Dependent
(A) UCP1 and co-expressed gene mRNA levels in high (n = 20), medium (n = 59), and low (n = 210) UCP1-expressing groups at baseline.
(B) UCP1 and co-expressed gene mRNA levels in males (n = 101) and females (n = 188).
(C) UCP1 and co-expressed gene mRNA levels in individuals recruited in winter (n = 77), spring (n = 98), summer (n = 40), and autumn (n = 74).
Data are mean ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001 for high andmedium versus lowUCP1 (A), for females versus males (B), and for summer and autumn
versus winter (C); #p < 0.05, ##p < 0.01, and ###p < 0.001 for medium versus high UCP1 (A). See also Figures S1 and S2 and Table S2.significantly lower in individuals recruited in summer and
autumn compared with those recruited in winter (Figure 1C). A
similar pattern was found for ELOVL3, CKMT1a, and CKMT2.
These results suggest that browning of subcutaneous abdom-
inal WAT, similarly to BAT activity, is higher in winter in humans
(Au-Yong et al., 2009; Kern et al., 2014). Recruitment of males
and females did not differ according to the recruitment season
(Figure S2I), suggesting that sex differences were not biased
by a seasonal effect.Gene Expression of Brown and Beige Markers in
Subcutaneous Abdominal WAT Is Decreased during CR
Next, we used the DiOGenes trial to investigate the relationship
between CR and browning ofWAT (Figure S3). The 8 week VLCD
promoted substantial weight loss (11%) and decrease in
body fat and improved insulin sensitivity (Table 2; Figure 2A).
Correlation matrix analysis of genes according to CR-induced
changes revealed 11 clusters (Figure S4). One cluster included
UCP1, ELOVL3, CKMT1A, and CKMT2. These genes showedCell Reports 22, 1079–1089, January 23, 2018 1081
Table 2. Clinical Parameters of 289 Individuals with Obesity during the Two-Phase Dietary Intervention
Baseline End of VLCD End of WMP
Males (n = 101) Females (n = 188) Males (n = 101) Females (n = 188) Males (n = 101) Females (n = 188)
Age (years) 43.4 ± 5.9 41.7 ± 6.4 43.4 ± 5.9 41.7 ± 6.4 43.4 ± 5.9 41.7 ± 6.4
Weight (kg) 106.6 ± 17.3 95.0 ± 14.4 93.8 ± 15.3*** 84.9 ± 13.0*** 95.1 ± 16.2*** 84.5 ± 13.3***
BMI (kg/m2) 33.7 ± 4.6 34.5 ± 4.6 29.6 ± 4.1*** 30.8 ± 4.2*** 30.0 ± 4.2*** 30.7 ± 4.4***
Body fat (%) 31.4 ± 6.8 43.5 ± 5.0 27.0 ± 5.7*** 39.8 ± 5.6*** 26.4 ± 5.6*** 38.8 ± 6.1***
HOMA-IR 2.9 ± 1.7 2.3 ± 1.4 1.7 ± 1.1*** 1.5 ± 0.9*** 2.3 ± 2.3** 1.7 ± 1.1***
HOMA-IR, homeostatic model assessment of insulin resistance ([fasting glucose (mM) 3 fasting insulin (mU/L)/22.5]; VLCD, 8 week very low calorie
diet; WMP, 6 month weight-maintenance phase. Data are mean ± SEM. **p < 0.01 and ***p < 0.001 for end of VLCD and end of WMP versus baseline.
No significant difference was observed between end of VLCD and end of WMP.decreased expression during VLCD (Figure 2B). Simultaneous
downregulation of UCP1 and CKMTs suggests that the two
thermogenic pathways are diminished during CR. Another clus-
ter composed of mitochondrial electron transport chain genes
(namely, NDUFA11, NDUFB6, CYC1, COX4I1, and COX8A)
showed the same pattern (Figure 2C). Downregulation of gene
expression during CR was also found when males and females
were analyzed separately (Figures S5A–S5C). Although season
at recruitment influenced baseline expression of thermogenic
markers, CR decreased expression of the genes independently
of the season (Figure 3). These data reveal that CR decreases
browning and the thermogenic potential of human subcutaneous
abdominal WAT and show that CR-induced metabolic improve-
ments in humans with obesity are not mediated by browning of
this fat depot. This finding is coherent with the well-established
decrease in resting metabolic rate and sympathetic nervous
system activity observed during CR and weight loss in humans
with obesity (Arone et al., 1995; Snitker et al., 2000; Cle´ment
et al., 2004; Heilbronn et al., 2006; Schwartz and Doucet,
2010). Accordingly, resting energy expenditure determined
in 34 DiOGenes subjects by indirect calorimetry was significantly
decreased (p < 0.001) during CR (data not shown). However, this
observation of clinical relevance is opposite to what has recently
been reported in mice (Fabbiano et al., 2016). The differences
between mice and humans may partly be explained by an
increased sensitivity to cold during fasting in mice that does
not occur in humans in habitual living conditions (Cinti, 1999).
Furthermore, the present study was focused exclusively on
subcutaneous abdominal WAT. As human classical BAT depots
were found to somewhat resemble murine beige inguinal WAT at
a molecular level (Sharp et al., 2012; Shinoda et al., 2015; Wu
et al., 2012), we cannot rule out that other fat pads (e.g., cervical,
supraclavicular, or paravertebral depots) may display different
responses to CR in humans.
Gene Expression of Brown and Beige Markers in
Subcutaneous Abdominal WAT Does Not Follow
Changes in Body Fat and Insulin Sensitivity during a
Two-Phase Weight-Loss Dietary Program
We sought to investigate browning of WAT at baseline and at the
end of the 8 month DiOGenes trial (Figure S3). Individuals were
classified according to changes in UCP1 gene expression
between baseline and end of weight-maintenance phase (Fig-
ure 4A). Some individuals showed increases, whereas others1082 Cell Reports 22, 1079–1089, January 23, 2018showed no change or decreases in UCP1 and browning marker
expression (Figures 4A–4D, right, middle, and left, respectively).
These inter-individual differences in WAT gene expression are
coherent with the reported variability of response in BAT activity
andWATUCP1mRNA expression during weight loss of a few in-
dividuals (Oliveira et al., 2016; Orava et al., 2013; Rachid et al.,
2015; Vijgen et al., 2012; Nakhuda et al., 2016). Despitemarkedly
different regulation of gene expression, the decrease in body fat
(12%–13%) was similar in the three groups (Figure 4E). Because
the DiOGenes trial is composed of two phases, an initial 8 week
VLCD phase and a 6 month weight-maintenance phase (Fig-
ure S3), we further explored the relationship between expression
of the 70 selected genes and patterns of body fat during the two
phases. The large number of individuals allowed cluster analysis
of fat percentage trajectories (Figure S6A). Among the four
profiles identified (Figure S6B), groups 1 and 2 showed similar
adiposity at baseline but divergent responses (mild and pro-
nounced body fat loss, respectively) to CR. During the follow-
up period, groups 3 and 4 displayed opposite patterns, as group
3 regained body fat up to initial level, whereas group 4 further lost
fat. The trajectory of the genes we identified as markers of
browning (i.e., UCP1, ELOVL3, CKMT1A, and CKMT2) did
not superimpose with the trajectory of body fat (Figures 5A–
5D; Table S3). Two complementary multivariate analyses (partial
least squares discriminant analysis [PLS-DA] and random forest)
were applied in order to identify discriminating genes respon-
sible for classification of patients into groups 1 or 2 during the
VLCD phase and into groups 3 or 4 during the weight-mainte-
nance phase (Breiman, 2001; Pe´rez-Enciso and Tenenhaus,
2003). LEP and DPT were identified within top-ranking
genes by the two methods during CR and follow-up phases
(Table S4). Fat percentage and LEP and DPT mRNA levels at
baseline were similar in groups 1 and 2 (Figures 5E and 5F). After
the VLCD, similar to variation in body fat, the decreases in LEP
and DPT mRNA levels were more pronounced in group 2 than
in group 1. During the follow-up period, the body fat return to
baseline value in group 3 was associated with increased LEP
expression. Conversely, body fat and DPT mRNA level simulta-
neously decreased in group 4 between the end of VLCD and
the end of the protocol. The concordance in the evolution of
body fat and leptin gene expression was expected and
validated our methodology (Maffei et al., 1995). DPT encodes a
non-collagenous component of the extracellular matrix, which
is a white adipocyte-specific marker (Petrovic et al., 2010). As
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Figure 2. Expression of Browning Markers in Subcutaneous Abdominal White Adipose Tissue Is Decreased during Caloric Restriction
(A) Body fat and homeostatic model assessment of insulin resistance (HOMA-IR) before (baseline) and at the end of the 8 week very low calorie diet (VLCD).
(B) mRNA levels of UCP1 and co-regulated brown fat markers.
(C) mRNA levels of mitochondrial electron transport chain subunits.
Data are mean ± SEM. ***p < 0.001 for end of VLCD versus baseline. See also Figures S3A, S4, and S5.modifications in the composition of WAT extracellular matrix is a
hallmark of obesity (Henegar et al., 2008), our data suggest that
DPT might play a role in the remodeling of WAT during cycles of
weight gain and loss.
A similar approach was used to identify genes whose expres-
sion was potentially associated with changes in the homeostatic
model assessment of insulin resistance (HOMA-IR). Clustering of
HOMA-IR trajectories identified three groups. Group 1 displayed
high baseline values and a fall during VLCD, whereas groups 2
and 3 had lower baseline values with moderate decrease upon
CR, leading to similar values in the three groups at the end of
VLCD (Figures S6C and S6D). During weight maintenance,
group 2 showed a further decrease in HOMA-IR, whereas
groups 1 and 3 showed significant increases. Changes in
expression of browning markers did not match changes in
HOMA-IR (Figures S6E–S6H). Multivariate analyses did not iden-
tify genes robustly associated with changes in HOMA-IR (data
not shown). These results suggest that subcutaneous abdominalWAT expression of the genes investigated in this study, including
browning markers, is not associated with variation in insulin
sensitivity during dietary intervention.
Relevance and Limitations of Studying Subcutaneous
Abdominal WAT during a Large-Scale Dietary
Intervention
Subcutaneous fat is by far the largest fat depot in the body and is
worth investigating as such with respect to browning. Although
visceral fat is also associated with impaired glucosemetabolism,
it is the subcutaneous abdominal fat region that supplies the
major quantity of plasma free fatty acids implicated in metabolic
abnormalities (Abate et al., 1995; Koutsari and Jensen, 2006). Of
note, molecular adaptations in subcutaneous and visceral fat
have the same discriminatory power with respect to insulin
resistance, abdominal obesity, and metabolic syndrome despite
a subset of genes being differentially expressed in the two
depots (Klimca´kova´ et al., 2011). Brown-like adipocytes inCell Reports 22, 1079–1089, January 23, 2018 1083
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Figure 3. Caloric Restriction Regulates Expression of Browning Markers in Subcutaneous Abdominal White Adipose Tissue Independently
of the Season
(A–D) mRNA levels of UCP1 and co-regulated brown fat markers at baseline and at the end of the 8 week very low calorie diet (VLCD) in individuals recruited in
winter (n = 77, left), spring (n = 98, middle left), summer (n = 40,middle right), and autumn (n = 74, right). (A)UCP1, (B) ELOVL3, (C)CKMT1A, and (D)CKMT2mRNA
levels.
Data are mean ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001 for end of VLCD versus baseline. See also Figure S3A.subcutaneous WAT favor oxidation of fatty acids and may limit
their release into the circulation (Barquissau et al., 2016; Tiraby
et al., 2003). We show here that this mechanism is unlikely to
contribute to the beneficial effects of diet-induced weight loss.
The present results may not be directly extrapolated to BAT
depots such as supraclavicular fat (Cypess et al., 2013; Lidell
et al., 2013; Jespersen et al., 2013). However, despite the
marked heterogeneity in the occurrence of human brown and
beige adipocytes according to anatomical location, similar regu-
lation may be observed in BAT depots as those reported here in
subcutaneous fat. Supporting this view, we show that subcu-
taneous abdominal WAT browning appears to be physiologically
regulated by sex and season, similar to what has been observed
in BAT (Au-Yong et al., 2009; Cypess et al., 2009; Kern et al.,1084 Cell Reports 22, 1079–1089, January 23, 20182014; Nookaew et al., 2013). A limitation of the present study is
its focus on a single WAT depot (i.e., the subcutaneous abdom-
inal fat pad), which might be resistant to browning in humans
contrary to rodents. However, it was recently reported that
burn trauma patients showed browning of subcutaneous WAT
after severe adrenergic stress (Sidossis et al., 2015). Pheochro-
mocytoma and cancer-associated cachectic patients also dis-
played morphological and molecular features of beige fat in
various abdominal fat depots (Frontini et al., 2013; Petruzzelli
et al., 2014). Altogether, these results from independent groups
suggest that human abdominal WAT depots are endowed with
browning capacity and that stimuli (e.g., CR) are unlikely to
induce ‘‘whitening’’ of subcutaneous abdominal WAT while
promoting browning of other fat pads. As to whether the data
AB
C
D
Baseline End of WMP
0.000
0.001
0.002
0.003
0.004
***
U
C
P1
 m
R
N
A
 le
ve
l (
A
.U
.)
Baseline End of WMP
0.000
0.001
0.002
0.003
0.004
U
C
P1
 m
R
N
A
 le
ve
l (
A
.U
.)
Baseline End of WMP
0.000
0.001
0.002
0.003
0.004
***
U
C
P1
 m
R
N
A
 le
ve
l (
A
.U
.)
Baseline End of WMP
0.00
0.05
0.10
0.15
0.20
0.25
EL
O
VL
3
m
R
N
A
 le
ve
l (
A
.U
.)
Baseline End of WMP
0.00
0.05
0.10
0.15
0.20
0.25
EL
O
VL
3
m
R
N
A
 le
ve
l (
A
.U
.)
Baseline End of WMP
0.00
0.05
0.10
0.15
0.20
0.25
***
EL
O
VL
3
m
R
N
A
 le
ve
l (
A
.U
.)
Baseline End of WMP
0.00
0.01
0.02
0.03
**
C
K
M
T1
A
 m
R
N
A
 le
ve
l (
A
.U
.)
Baseline End of WMP
0.00
0.01
0.02
0.03
C
K
M
T1
A
 m
R
N
A
 le
ve
l (
A
.U
.)
Baseline End of WMP
0.00
0.01
0.02
0.03
***
C
K
M
T1
A
 m
R
N
A
 le
ve
l (
A
.U
.)
Baseline End of WMP
0.0
0.2
0.4
0.6
0.8
C
K
M
T2
 m
R
N
A 
le
ve
l (
A
.U
.)
Baseline End of WMP
0.0
0.2
0.4
0.6
0.8
***
C
K
M
T2
 m
R
N
A
 le
ve
l (
A
.U
.)
Baseline End of WMP
0.0
0.2
0.4
0.6
0.8
***
C
K
M
T2
 m
R
N
A
 le
ve
l (
A
.U
.)
Baseline End of WMP
0
20
40
60
***
B
od
y 
fa
t (
%
)
Baseline End of WMP
0
20
40
60
***
B
od
y 
fa
t (
%
)
Baseline End of WMP
0
20
40
60
***
B
od
y 
fa
t (
%
)
E
UCP1 mRNA fold change > 2 UCP1 mRNA fold change < 0.50.5 < UCP1 mRNA fold change < 2
Figure 4. Changes in Expression of Browning Markers in Subcutaneous Abdominal White Adipose Tissue between Baseline and 6 Months
after Caloric Restriction Display High Inter-individual Variability
(A–D) mRNA levels of UCP1 and co-regulated brown fat markers at baseline and at the end of the weight-maintenance phase (WMP). (A) UCP1, (B) ELOVL3,
(C) CKMT1A, and (D) CKMT2 mRNA levels.
(E) Body fat percentage at baseline and at the end of WMP.
Data are mean ± SEM. **p < 0.01 and ***p < 0.001 for end of WMP versus baseline. See also Figure S3A.
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Figure 5. Expression of BrowningMarkers in Subcutaneous Abdominal White Adipose Tissue Does Not FollowChanges in Body Fat during a
Two-Phase Weight Loss Dietary Program
(A–F) Variation in mRNA levels (full lines) according to four profiles of changes in fat percentage (dashed lines). (A) UCP1, (B) ELOVL3, (C) CKMT1A, (D) CKMT2,
(E) LEP, and (F) DPT mRNA levels.
Data are mean ± SEM. Clustering of body fat percentage is shown in Figure S6. Statistical significance is provided in Table S4. VLCD, very low calorie diet;
WMP, weight-maintenance phase. See also Figures S3A and S6 and Tables S3 and S4.reported on diet-induced weight loss can be extrapolated to
bariatric surgery-induced weight loss is a more challenging
question. Indeed, several studies recently reported bariatric
surgery-induced BAT activation and WAT browning in the neck1086 Cell Reports 22, 1079–1089, January 23, 2018region (Neinast et al., 2015; Oliveira et al., 2016; Rachid et al.,
2015; Vijgen et al., 2012). Beyond the aforementioned hypothet-
ical opposite response to CR of distinct WAT depots, these
apparently contradictory findings may be accounted for by the
numerous physiological adaptations occurring after bariatric
surgery in addition to the sole decrease in energy intake.
Although CR per se is important, gastrointestinal hormones,
bile acids, gut microbiota, and neurohormonal adaptations
play specific roles in bariatric surgery-induced weight loss and
improved glucose metabolism and may contribute to fat brown-
ing (Chondronikola et al., 2016; Liou et al., 2013; Neinast et al.,
2015; Rachid et al., 2015; Vijgen et al., 2012). Future work inves-
tigating human fat samples from several anatomical locations
during diet-induced energy deprivation, a technical and ethical
challenge, would help establishing whether there is coordinated
or differential response to CR of various fat depots with different
thermogenic potentials.
In conclusion, studies on limited numbers of subjects may not
be relevant given the large variability of fat browning in individ-
uals with obesity. Investigating the relationship between brown-
ing markers and CR, body fat loss, and insulin sensitivity is
possible only when several hundred individuals are investigated.
Cellular markers previously identified as beige or brown specific
have weak relevance in vivo in studying human whole WAT.
Despite higher percentage of body fat, women with obesity
display more browning features in subcutaneous abdominal
WAT than men. CR is associated with impairment of browning
in that fat depot. Whether this regulation is observed in other
fat depots with higher content of brown and beige fat cells is
not established. As CR simultaneously decreases adiposity
and improves insulin sensitivity, the hypothesis of a contribution
of subcutaneous abdominal WAT browning to weight loss-
induced metabolic benefits proves not to be relevant in humans.
EXPERIMENTAL PROCEDURES
Further details and an outline of resources used in this work can be found in
Supplemental Experimental Procedures.
DiOGenes Trial
DiOGenes was amulticenter dietary intervention study whose design has been
previously described (Figure S3A) (Larsen et al., 2010). Briefly, adults with
overweight and obesity participated in a dietary program with an 8 week
VLCD (3.3–4.2MJ/day). Volunteerswithweight changes > 3 kgwithin 2months
prior to the beginning of CR were not included. Individuals achieving at least
8% of weight loss were randomized to a 6 month weight-maintenance phase
with ad libitum diets. Five hundred forty-eight volunteers completed the whole
intervention, and the present findings were obtained in 289 patients (Fig-
ure S3A), including 188 females (age 41.7 ± 6.4 years) and 101 males (age
43.4 ± 5.9 years). The study was approved by the local ethical committees
in the respective countries in accordance with the Declaration of Helsinki. All
study participants signed an informed consent document after verbal and writ-
ten instructions that followed local legislation.
Quantification and Statistical Analysis
R software (version 3.2.2) was used for individuals’ classification, random
forests, and PLS-DA using different R packages (see below). Conventional
statistical analyses were carried out using GraphPad Prism (version 5.0).
Gaussian distribution of data were tested using the D’Agostino and Pearson
omnibus test. Group comparisons were performed using one-way ANOVA
(normally distributed data) or Kruskal-Wallis, Wilcoxon (paired data), and
Mann-Whitney (unpaired data) tests (skewed data). Correlation coefficients
were calculated using Pearson (normally distributed data) or Spearman
(skewed data) correlations.
Hierarchical clustering analysis on UCP1 mRNA levels was used to deter-
mine high, medium, and low UCP1-expressing groups. Euclidean distancewas used as a measure of similarity, and Ward’s method was chosen as
agglomeration criteria. The dendrogram obtained was cut into three groups
(Figure S1C). For body fat and HOMA-IR trajectories, grouping was performed
among patients with available body fat or HOMA-IR data at each time points
(n = 179 and 219, respectively) using hierarchical clustering analysis on a
matrix composed of two synthetic variables, V1 and V2. V1 was calculated
as the difference in body fat (or HOMA-IR) between end of VLCD and baseline
and V2 as the difference in body fat (or HOMA-IR) between the end of the
weight-maintenance phase and the end of VLCD. The dendrograms obtained
for body fat and HOMA-IR were cut into four and three groups, respectively
(Figures S6A and S6C). Groups were then hand-cleaned from borderline
individuals and wrong group assignment on the basis of body fat (or HOMA-IR)
trajectories to obtain more homogeneous clusters, resulting in a final analysis
of 157 (181) individuals (Figures S6B and S6D).
Two multivariate discriminant analyses were used to identify the important
variables (i.e., mRNA levels) for group classification: PLS-DA (R package
mixOmics) and random forest (R package randomForest). PLS-DA is a PLS
approach in which only one dependent variable represents the class or group
membership (Pe´rez-Enciso and Tenenhaus, 2003). The variable influence on
projection (VIP) indicates the influence of each variable on the discrimination
between the different groups. Random forest is an ensemble of classification
trees calculated on random subsets of the data, using a subset of randomly
selected variables for each split in each classification tree (Breiman, 2001).
Mean decreased Gini (MDG) is used as an indicator of importance of the vari-
ables. These two methods were chosen because of their complementarity:
PLS-DA is a method taking place in a linear framework, whereas random
forest is a nonlinear one. For each phase of the dietary intervention, the
most important transcripts in the classification were ranked according to
decreasing VIP or MDG. A classification score was calculated as the sum
of the rank for each gene.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and four tables and can be found with this article online at
https://doi.org/10.1016/j.celrep.2017.12.102.
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Supplemental Figure 1, related to Figure 1 
(A) Venn diagram showing the number of genes specific of each adipocyte type according to the literature and this article data. 
(B) Correlation matrix of the 12 cell type-specific markers and UCP1. Subsets of genes shown in boxes were identified by 
hierarchical clustering. 
(C) Cluster dendrogram of UCP1 gene expression in 289 individuals at baseline. Three groups with high, medium and low UCP1
mRNA levels were defined.
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Supplemental Figure 2, related to Figure 1
(A-G) Sex effect on UCP1 and co-expressed gene mRNA levels in high (n=0 and 20 in males and females, respectively), medium 
(n=4 and 55 in males and females, respectively) and low (n=97 and 113 in males and females, respectively) UCP1 expressing 
groups. (A) UCP1, (B) ELOVL3, (C) CKMT1A, (D) CKMT2, (E) PPARGC1B, (F) PCK1 and (G) PLIN5 mRNA levels.
Data are means ± SEM. *, ** and ***: p < 0.05, 0.01 and 0.001 for high and medium vs low UCP1; #: p < 0.05 for medium vs
high UCP1.
(H) Number of males and females in each UCP1 group (white bars, females; black bars, males). Contingency analysis showed 
significant differential distribution of males and females. (I) Number of males and females recruited at different seasons (white 
bars, females; black bars, males). Contingency analysis showed no significantly different distribution of males and females.
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Supplemental Figure 3, related to Figures 2, 3, 4 and 5 and Table 2
(A) Overview of the DiOGenes protocol.
(B) Flowchart of patient and sample selection.
CID, clinical investigation day. PCA, principle component analysis. RT-qPCR, reverse transcription quantitative polymerase chain
reaction. VLCD, very low calorie diet. WMP, weight maintenance phase.
Supplemental Figure 4, related to Figure 2
Correlation matrix of changes in mRNA levels during very low calorie diet. Eleven clusters (boxes) were identified using a 
seriation algorithm to optimally reorder the genes and highlight the clusters.
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Supplemental Figure 5, related to Figure 2
(A) Body fat and homeostatic model assessment – insulin resistance (HOMA-IR) at baseline and at the end of 8-week very low 
calorie diet (VLCD) in males (left and middle-left panels and females (middle-right and right panels).
(B) mRNA levels of UCP1 and co-regulated brown fat markers.
(C) mRNA levels of mitochondrial electron transport chain subunits.
Data are means ± SEM. *, ** and ***: p < 0.05, 0.01 and 0.001 for end of VLCD vs baseline.
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Supplemental Figure 6, related to Figure 5
(A,C) Cluster dendrograms of fat percentage (A) and HOMA-IR (C) trajectories between baseline and end of the two-phase 
dietary intervention. 
(B) Profiles of changes in fat percentage in the four groups shown in A (n=72, 37, 24 and 24 in groups 1, 2, 3 and 4, respectively).
(D) Profiles of changes in HOMA-IR  in the three groups shown in B (n=50, 53 and 78 in groups 1, 2 and 3, respectively).
(E-H) Variation in mRNA levels according to three profiles of changes in HOMA-IR identified in C-D. (E) UCP1, (F) ELOVL3, 
(G) CKMT1A and (H) CKMT2 mRNA levels.
VLCD, very low calorie diet, WMP, weight maintenance phase. Data are means ± SEM.
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Table S1. List of analysed genes, related to Method details and Figure S1A. 
See content in accompanying Excel file. 
  
Table S2. Correlation analyses between UCP1 and co-expressed genes according to 
UCP1 expression and sex at baseline, related to Figure 1. 
 High and 
medium 
UCP1 
expression 
(n=79) 
 Low 
UCP1 
expression 
(n=210) 
 Males 
(n=101) 
 Females  
(n=188) 
 
Gene name r p value r p value r p value r p value 
ELOVL3 0.35 2*10-3 0.38 < 10-8 0.10 0.34 0.47 < 10-10 
CKMT2 0.26 0.02 0.44 < 10-10 0.21 0.04 0.37 < 10-6 
CKMT1A 0.29 0.01 0.34 < 10-6 0.24 0.02 0.40 < 10-7 
PPARGC1B 0.17 0.13 0.31 < 10-5 0.32 10-3 0.34 < 10-5 
PCK1 0.32 4*10-3 0.27 < 10-4 0.27 6*10-3 0.35 < 10-6 
PLIN5 0.31 6*10-3 0.15 0.03 0.14 0.16 0.32 < 10-5 
  
Table S3. Statistical analyses, related to Figure 5. 
 Cluster 
1 (n=72)
  Cluster 
2 (n=37)
  Cluster 
3 (n=24) 
  Cluster 
4 (n=24)
  
 Baseline 
vs end 
of 
VLCD 
Baseline 
vs end 
of WMP 
End of 
VLCD 
vs end 
of WMP
Baseline 
vs end 
of 
VLCD 
Baseline 
vs end 
of WMP
End of 
VLCD 
vs end 
of WMP
Baseline 
vs end 
of 
VLCD 
Baseline 
vs end 
of WMP
End of 
VLCD 
vs end 
of WMP
Baseline 
vs end 
of 
VLCD 
Baseline 
vs end 
of WMP
End of 
VLCD 
vs end 
of WMP 
Body fat 
(%) 
< 0.001 < 0.001 ns < 0.001 < 0.001 ns <0.001 <0.05 < 0.001 < 0.05 < 0.001 < 0.001 
UCP1 < 0.001 < 0.01 < 0.05 ns ns ns ns ns < 0.05 ns ns ns 
ELOVL3 < 0.05 ns ns ns ns ns ns ns ns < 0.05 ns ns 
CKMT1a < 0.05 ns ns ns ns ns ns ns ns ns ns ns 
CKMT2 < 0.001 < 0.001 ns < 0.001 ns < 0.01 ns ns < 0.001 < 0.001 < 0.001 ns 
LEP < 0.001 < 0.001 Ns < 0.001 < 0.001 ns < 0.001 ns < 0.001 < 0.001 < 0.001 ns 
DPT ns < 0.001 <0.001 ns < 0.001 < 0.001 ns ns ns ns < 0.001 < 0.01 
VLCD, very low calorie diet. WMP, weight maintenance phase. ns, non significant (p value > 0.05) 
 
 
  
 
Table S4. Multivariate analyses according to the four profiles defined by cluster analysis 
of body fat evolution during the multiple phase dietary intervention, related to Figure 5. 
Gene name PLS-DA rank RF rank Combined rank 
Discrimination 
between groups 1 and 
2 who showed similar 
body fat at baseline but 
divergent body fat loss, 
during very low calorie 
diet 
RIP140 4 2 1 
DPT 1 6 2 
LEP 5 4 3 
CKMT2 6 5 4 
ELOVL3 2 10 5 
Discrimination 
between group 3 who 
regained body fat and 
group 4 who lost body 
fat during ad libitum 
follow up diets 
LEP 1 1 1 
DPT 2 2 2 
CA3 3 3 3 
ANGPTL4 4 4 4 
NDUFB6 5 6 5 
PLS-DA, partial least quare discriminant analysis. RF, random forest 
Supplemental experimental procedures 
Further information and requests for resources and reagents should be directed to and will be 
fulfilled by the Lead Contact, Dominique Langin (dominique.langin@inserm.fr).” 
 
Experimental models and subject details 
Additional human fat samples for cell type isolation 
Abdominal subcutaneous adipose tissue samples were obtained from 6 women and 1 men 
(age 40 ± 1.1 years, BMI 25 ± 0.8 kg/m²) undergoing abdominal dermolipectomy at Rangueil 
university hospital, Toulouse, France. None of the patients had recent large variations in body 
weight. The volunteers signed informed consent for an anonymous use of samples. 
hMADS adipocyte culture and browning 
Human multipotent adipose-derived stem (hMADS) cells established from the prepubic fat 
pad of a 4-month-old male were cultured and differentiated into white adipocytes within 14 
days. Browning of white adipocytes was induced by addition of rosiglitazone between day 14 
and day 18 (Barquissau et al., 2016). Six independent replicates of both white and beige fat 
cells were harvested for RNA extraction at day 18.  
 
 
 
 
 
Method details 
DiOGenes investigation days 
At each clinical investigation day (i.e., at baseline, after VLCD and after weight maintenance 
phase), bio-clinical data were collected, blood was sampled and a needle biopsy of abdominal 
subcutaneous WAT was performed in the morning after overnight fast. Body fat was assessed 
with the use of dual-energy x-ray absorptiometry or bioelectrical impedance analysis. 
 
Adipocyte and stromavascular cell isolation 
Adipose tissue was cleaned and digested by collagenase as previously described (Klimcakova 
et al., 2011). 
 
RNA extraction 
Fat samples from DiOGenes trial were processed following an in-house optimized protocol 
for total RNA preparation (Viguerie et al., 2012). Briefly, frozen AT sample was 
homogenized in QIAzol (Qiagen) using a rotor-stator homogenizer until homogeneity. After 
addition of chloroform and centrifugation, the aqueous phase was transferred onto column 
(RNeasy mini kit, Qiagen) and processed following manufacturer instructions. 
Separated mature adipocytes, stromavascular cells and hMADS adipocytes were collected for 
total RNA extraction using RNeasy mini kit (Qiagen). 
 
 
Gene expression analysis from human adipose tissue and cell samples 
RNA quality of human and cell samples was checked by capillary electrophoresis (Experion, 
Bio-Rad). cDNA synthesis (High-Capacity cDNA Reverse Transcription Kit, Applied 
Biosystems) and massive parallel real-time PCR using the Biomark HD system with 96.96 
Dynamic Array IFC (Fluidigm) and TaqMan assays (Applied Biosystems) were performed as 
described (Viguerie et al., 2012). Using geNorm software, PUM1 was identified as the most 
stable gene among the whole gene set (including 3 potential housekeeping genes: PUM1, 
LRP10 and GUSB) and used as reference gene to normalize mRNA levels using the 2-ΔCt 
method. 
 
Gene selection and classification 
Ninety genes related to adipose metabolism and to adipocyte subtype identity were selected 
(Table S1). Genes reported in the literature to discriminate between white, beige and brown 
adipocytes were included in the “white-”, “beige-” and “brown-fat marker” categories, 
respectively. Classical and recently described thermogenic and oxidative markers, as well as 
genes up-regulated during browning of hMADS cells were grouped in the “brown-beige fat 
marker” category. Additional genes that could play a role in adipose metabolism, which were 
not significantly increased in hMADS cells after browning and which were not found in the 
literature to be specifically enriched in one adipose subtype, were considered as “adipocyte 
markers”. Genes supposed to belong to one of the above categories but showing higher 
expression in stromavascular fraction cells (stromavascular fraction vs adipocyte ratio > 2) 
were classified in the “stromavascular fraction cell marker” category. 
  
Resource table 
REAGENT or RESOURCE SOURCE IDENTIFIER
Biological Samples   
DiOGenes adipose tissue RNA samples Prof. Dominique 
Langin on behalf of 
the DiOGenes 
consortium 
Dominique.Langin
@inserm.fr 
Chemicals, Peptides, and Recombinant Proteins 
QIAzol Qiagen Cat#79306 
Critical Commercial Assays 
RNeasy mini kit Qiagen Cat#74106 
High-Capacity cDNA Reverse Transcription Kit Thermo Fischer 
Scientific 
Cat#4368814 
PreAmp Master Mix kit Fluidigm PN 100-5581 
TaqMan Universal PCR Master Mix kit Thermo Fischer 
Scientific 
PN 4304437 
Experimental Models: Cell Lines 
Human Multipotent Adipose-Derived Stem cells Dr. Ez-Zoubir Amri, 
Nice, France 
Ez-
Zoubir.AMRI@uni
ce.fr 
Oligonucleotides 
Taqman assays for qPCR Thermo Fischer 
Scientific 
See Table S1 
Software and Algorithms 
geNorm software (Vandesompele et 
al., 2002) 
https://genorm.cm
gg.be/ 
GraphPad Prism software, version 5.0 GraphPad Software https://www.graph
pad.com/scientific-
software/prism/ 
R software, version 3.2.2 R Core Team 2017 
R: A language and 
environment for 
statistical 
computing. R 
Foundation for 
Statistical 
Computing, Vienna, 
Austria. 
https://www.r-
project.org/ 
R “mixOmics” package (Le Cao et al., 2009) http://mixomics.or
g/ 
R “random forests” package Liaw and Wiener 
2002 R news 2:18-
22 
https://cran.r-
project.org/web/pa
ckages/randomFor
est/index.html 
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